New Delhi [India], Sep 28 (NewsVoir): PATH welcomes the World Health Organization's (WHO's) prequalification of the thermostable rotavirus vaccine, ROTASIIL®, manufactured by Serum Institute of India.
Pune (Maharashtra) [India], Sept 26 (ANI-NewsVoir): Results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd.'s rotavirus vaccine BRV-PV (known as ROTASIIL) were published in the journal Vaccine.